Hua et al. [22] identified GOLPH3 as an important prognostic factor for patients with PCa; Jonsson et al. [23] demonstrated that high RBM3 expression in PCa may independently predict a reduced risk of BCR and disease progression. This evidence concerns the gene RBM3 and posterior cortical atrophy.